article thumbnail

Key Pharmaceutical Use Cases for Embracing AI

Dataiku

According to a survey of 1,200 global companies sponsored by Dataiku in September 2020, 66% of life sciences or pharmaceutical organizations believe AI is either considerably or very important to the future of their business. This goes to show the immense potential that AI and machine learning have in the pharmaceutical industry.

article thumbnail

The ‘Great Retraining’: IT upskills for the future

CIO

From an individual’s perspective, it keeps careers interesting and helps people grow with the organization. Instead, a good portion of the IT organization embeds with scientists and other drug specialists to immerse in the various research initiatives, uncover the potential for IT innovation, and map the requisite technologies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

China’s WuXi AppTec shared US client’s data with Beijing, US intelligence officials told senators

Ooda Loop

In February, US Intelligence officials informed senators that the Chinese pharmaceutical firm WuXi AppTec had given China U.S. This joining briefing was delivered by the FBI, Department of State, and Office of the Director of National Intelligence and informed senators that Chinese organizations engaged in activity […]

article thumbnail

GxP in the Pharmaceutical Industry: What It Means for Dataiku and Merck

Dataiku

The pharmaceutical industry’s highly regulatory environment can be tremendously demanding for organizations navigating the space.

article thumbnail

54gene CEO steps down as the company looks to cut more jobs

TechCrunch

Founded in 2019 by Ene-Obong, 54gene addresses the gap in the global genomics market where Africans make up less than 3% of genetic material used in pharmaceutical research despite being more genetically diverse than any other population.

article thumbnail

Women IT leaders take center stage

CIO

Cultivating visibility matters for a few reasons,” says Kathryn Guarini, a former IBM CIO and now a board member at Regeneron Pharmaceuticals. Kathryn Guarini, board member, Regeneron Pharmaceuticals, and former IBM CIO Guarini “You want to be the one considered for opportunities to have an impact,” she says.

article thumbnail

Generative AI usage gains traction among enterprises: McKinsey

CIO

Almost 14% of the respondents said their organization was using generative AI in the marketing and sales division, followed by 13% and 10% of the respondents saying their organizations were making use of the new AI technology across product development and service operations, respectively.